News & Press Releases

WASHINGTON, DC – Mintz is pleased to welcome Michael Leib, former senior attorney-advisor to multiple commissioners at the US International Trade Commission (ITC), to the firm's Intellectual Property Practice as a Member in its Washington, DC, office.

Mintz advised the placement agents on the $200 Million private placement in connection with Processa Pharmaceuticals, Inc.’s acquisition of Vidya Therapeutics, Inc.

Mintz advised the placement agents in connection with LB Pharmaceuticals’ $150 Million private placement of common stock and pre-funded warrants.

Several attorneys in Mintz’s Intellectual Property Practice have been recognized in the 2026 edition of IP Stars, published by Managing IP. In addition to individual attorney recognitions, Mintz was recognized in the United States rankings for ITC Litigation, Life Sciences IP, Patent Disputes, PTAB Litigation, and Patent Prosecution.

Mintz advised Synlogic, Inc. in its definitive merger agreement with Caldera Therapeutics, Inc. in an all-stock transaction pursuant to which both companies will become wholly owned subsidiaries of a newly formed company that will operate as Caldera Therapeutics, Inc. The transaction is supported by an upsized $278 million concurrent private placement financing from a syndicate of new and existing investors and is expected to close concurrently with the completion of the merger.

Mintz has elevated John Koss to serve as the firm's first Chief Innovation & AI Officer, reinforcing Mintz's commitment to responsible AI adoption, practical innovation, and the future of technology-enabled legal services. In this newly created role, he will continue to lead Mintz's E-Data Consulting Group and Knowledge Management and Innovation team while overseeing the firm's innovation strategy, AI investments, and technology initiatives.